Literature DB >> 28966854

Retinal imaging in human autopsy eyes using a custom optical coherence tomography periscope.

Ryan P McNabb1, James Tian1, Sina Farsiu1,2, Joseph A Izatt1,2, Eleonora M Lad1, Anthony N Kuo1,2.   

Abstract

Age-related macular degeneration (AMD) is a major cause of vision loss in the elderly. To better study the pathobiology of AMD, postmortem eyes offer an excellent opportunity to correlate optical coherence tomography (OCT) imaging characteristics with histopathology. However, postmortem eyes from autopsy present challenges to standard OCT imaging including opaque anterior segment structures and standard of care autopsy processing resulting in oblique views to the macula. To overcome these challenges, we report a custom periscope attached by a standard mount to an OCT sample arm and demonstrate high quality macular OCT acquisitions in autopsy-processed eyes.

Entities:  

Keywords:  (170.0110) Imaging systems; (170.4470) Ophthalmology; (170.4500) Optical coherence tomography

Year:  2017        PMID: 28966854      PMCID: PMC5611930          DOI: 10.1364/BOE.8.004152

Source DB:  PubMed          Journal:  Biomed Opt Express        ISSN: 2156-7085            Impact factor:   3.732


  13 in total

1.  Ultrahigh-resolution ophthalmic optical coherence tomography.

Authors:  W Drexler; U Morgner; R K Ghanta; F X Kärtner; J S Schuman; J G Fujimoto
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440

2.  Wide field of view swept-source optical coherence tomography for peripheral retinal disease.

Authors:  Ryan P McNabb; Dilraj S Grewal; Rajvi Mehta; Stefanie G Schuman; Joseph A Izatt; Tamer H Mahmoud; Glenn J Jaffe; Prithvi Mruthyunjaya; Anthony N Kuo
Journal:  Br J Ophthalmol       Date:  2016-01-11       Impact factor: 4.638

3.  Quantitative classification of eyes with and without intermediate age-related macular degeneration using optical coherence tomography.

Authors:  Sina Farsiu; Stephanie J Chiu; Rachelle V O'Connell; Francisco A Folgar; Eric Yuan; Joseph A Izatt; Cynthia A Toth
Journal:  Ophthalmology       Date:  2013-08-29       Impact factor: 12.079

4.  In vivo retinal optical coherence tomography at 1040 nm - enhanced penetration into the choroid.

Authors:  Angelika Unterhuber; B Povazay; B Hermann; H Sattmann; A Chavez-Pirson; W Drexler
Journal:  Opt Express       Date:  2005-05-02       Impact factor: 3.894

5.  Swept source optical coherence microscopy using a 1310 nm VCSEL light source.

Authors:  Osman O Ahsen; Yuankai K Tao; Benjamin M Potsaid; Yuri Sheikine; James Jiang; Ireneusz Grulkowski; Tsung-Han Tsai; Vijaysekhar Jayaraman; Martin F Kraus; James L Connolly; Joachim Hornegger; Alex Cable; James G Fujimoto
Journal:  Opt Express       Date:  2013-07-29       Impact factor: 3.894

6.  Optical coherence microscopy in scattering media.

Authors:  J A Izatt; M R Hee; G M Owen; E A Swanson; J G Fujimoto
Journal:  Opt Lett       Date:  1994-04-15       Impact factor: 3.776

7.  Fully automated detection of diabetic macular edema and dry age-related macular degeneration from optical coherence tomography images.

Authors:  Pratul P Srinivasan; Leo A Kim; Priyatham S Mettu; Scott W Cousins; Grant M Comer; Joseph A Izatt; Sina Farsiu
Journal:  Biomed Opt Express       Date:  2014-09-12       Impact factor: 3.732

8.  Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments.

Authors:  David B Rein; John S Wittenborn; Xinzhi Zhang; Amanda A Honeycutt; Sarah B Lesesne; Jinan Saaddine
Journal:  Arch Ophthalmol       Date:  2009-04

9.  Distributed scanning volumetric SDOCT for motion corrected corneal biometry.

Authors:  Ryan P McNabb; Francesco Larocca; Sina Farsiu; Anthony N Kuo; Joseph A Izatt
Journal:  Biomed Opt Express       Date:  2012-08-10       Impact factor: 3.732

10.  Automatic segmentation of seven retinal layers in SDOCT images congruent with expert manual segmentation.

Authors:  Stephanie J Chiu; Xiao T Li; Peter Nicholas; Cynthia A Toth; Joseph A Izatt; Sina Farsiu
Journal:  Opt Express       Date:  2010-08-30       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.